Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

MK-8175A

No overview information available.

No background information available.

No indication information available.

No associated conditions information available.

Title	Posted	Study ID	Phase	Status	Sponsor
Study of the Contraceptive Efficacy and Safety of a NOMAC-E2 Combined Oral Contraceptive (COC)(P06448)	2012/08/03	NCT01656434	Phase 3	Terminated	Organon and Co
Effects on Ovarian Function of the Combined Oral Contraceptive NOMAC-E2 Compared to a COC Containing DRSP/EE (292003)(COMPLETED)(P05723)	2007/08/03	NCT00511433	Phase 3	Completed	Organon and Co
Efficacy and Safety of the Combined Oral Contraceptive (COC) NOMAC-E2 Compared to a COC Containing DRSP/EE (292001)(COMPLETED)(P05724)	2007/08/03	NCT00511199	Phase 3	Completed	Organon and Co
Effects on Hemostasis, Lipids, Carbohydrate Metabolism, Adrenal & Thyroid Function of the Combined Oral Contraceptive NOMAC-E2 Compared to a COC Containing LNG-EE (292004)(COMPLETED)(P05764)	2007/08/03	NCT00511355	Phase 3	Completed	Organon and Co
Effects on Bone Mineral Density (BMD) of the Combined Oral Contraceptive NOMAC-E2 Compared to a COC Containing LNG/EE (292005)(P05765)(COMPLETED)	2007/08/03	NCT00511342	Phase 3	Completed	Organon and Co
Efficacy and Safety Study of the Combined Oral Contraceptive NOMAC-E2 Compared to a COC Containing DRSP/EE (292002)(P05722)	2006/12/19	NCT00413062	Phase 3	Completed	Organon and Co

Product Name	Manufacturer	Route	Strength	Approved	NDC Code

No FDA products found for this drug

Medicine Name	EMA Number	Auth. Holder	Country	Drug Type	Status	Issued	Opinion	Revision

No EMA products found for this drug

Product Name	Manufacturer	Dosage Form	Strength	Approved	Approval No.	Online

No Singapore products found for this drug

No news found

Stay informed with timely notifications on clinical trials and research advancements.